#BIOTECH
🚨 Exciting news! IASO Bio's CAR-T therapy Fucaso has received BLA approval from Hong Kong's Department of Health for relapsed/refractory multiple myeloma. This marks a significant milestone for China-developed therapies! 🌏💉 #mikronews #Health #Biotech https://tinyurl.com/2xprorfd
November 27, 2025 at 6:26 PM
UK tree planting targets are failing – current rates are half what's needed and 22% of planted trees die. Edinburgh biotech Rhizocore pairs trees with site-matched fungi, lifting survival to 97%. Just raised £4.5m to scale. buff.ly/9MCHSTK #ClimateChange #Reforestation #NetZero
Why One In Five Planted Trees Die Before They Can Help Britain Reach Net Zero – And How Rhizocore Is Fixing It - Sovereign Magazine
UK tree planting lags targets, risking net zero aims. Edinburgh biotech Rhizocore pairs trees with fungi to lift survival to 97% and attract £4.5m to scale.
www.sovereignmagazine.com
November 27, 2025 at 6:19 PM
Vaccins anti-cancer : tout savoir sur la start-up française Transgene, qui vient de lever 100 millions d'euros

La biotech française Transgene, qui conçoit des vaccins destinés à traiter certains cancers, a levé 105 millions d'euros. Mais, quelle est cette start-up qui pourrait sauver la vie de...
Vaccins anti-cancer : tout savoir sur la start-up française Transgene, qui vient de lever 100 millions d'euros
La biotech française Transgene, qui conçoit des vaccins destinés à traiter certains cancers, a levé 105 millions d'euros. Mais, quelle est cette start-up qui
www.cnews.fr
November 27, 2025 at 6:24 PM
Clinical pragmatism: Eli Lilly $LLY GLP-1 revenue surge masks immunogenicity risk and looming HTA cost-effectiveness barriers. Expect margin mean-reversion as payers demand RWE. https://www.statnews.com/2025/11/24/biotech-news-can-a-glp-1-drug-slow-alzheimers/
November 27, 2025 at 6:07 PM
www.facebook.com/share/17eVZ3...

Daphne Koller had proven something universities didn't want to admit: Access had always been a design choice, not an educational requirement.
She left Coursera in 2016 to apply Al to drug discovery, founding a biotech company called Insitro.
Redirecting...
www.facebook.com
November 27, 2025 at 5:48 PM
Schlage hier auch gleich ein Parteiprogramm vor, das die PZD sofort adoptieren sollte, um sicher gewählt zu werden und dann durchziehen sollte, wenn sie nach der nächsten Wahl in der Regierung ist.
November 27, 2025 at 5:41 PM
Legend Biotech named Flanders' Foreign Investor of the Year for Ghent expansion
Legend Biotech named Flanders' Foreign Investor of the Year for Ghent expansion
The US biotechnology company Legend Biotech has been awarded Foreign Investor of the Year by Flanders Investment & Trade (FIT). The company...
www.belganewsagency.eu
November 27, 2025 at 5:22 PM
$SAVA Insider buying indicates undervaluation or an approaching positive catalyst. #StocksToWatch #Investing #StocksToBuy #StockMarket #Biotech
November 27, 2025 at 5:08 PM
Signal or noise? > Orphan Drugs Market to Surge to USD 486.51 Billion by 2032
as Rare Disease Innovation, Gene Therapies & Precision
Medicine Reshape Global Healthcare… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #pharma #biotech
Orphan Drugs Market to Surge to USD 486.51 Billion by 2032 as Rare Disease Innovation, Gene Therapies & Precision Medicine Reshape Global Healthcare - The AI Journal
Orphan Drugs Market to Surge to USD 486.51 Billion by 2032 as Rare Disease Innovation, Gene Therapies & Precision Medicine Reshape Global Healthcare  The AI Journal
dlvr.it
November 27, 2025 at 5:00 PM
Vaccins anti-cancer : la biotech française Transgene lève plus de 100 millions d’euros pour ses essais cliniques
🔗https://l.sudouest.fr/0g6i
November 27, 2025 at 4:37 PM
Ich hab auf einer Biotech-Messe mal einen Roboter gesehen, der autark Proben bearbeitet. Faszinierend, aber das Arbeitstempo 🥱

Fazit: für Einsätze in Gebieten mit hoch pathogenen Erregern ist das sicher genial. Aber nicht für den Alltag. Da ist der Mensch noch erheblich effektiver!
November 27, 2025 at 4:13 PM
Nnouvel épisode du podcast OMG! Décodons les biotech. Il traite du biocontrôle, un concept récent et à la définition floue. Il englobe des pratiques opposées : du purin d'orties aux pesticides génétiques.
@pollinis.org
@generationsfutures.fr
@bioconsomacteurs.org
podcast.ausha.co/omg-decodons...
November 27, 2025 at 4:06 PM
Signal or noise? > Orphan Drugs Market to Surge to USD 486.51 Billion by 2032
as Rare Disease Innovation, Gene Therapies & Precision
Medicine Reshape Global Healthcare… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #competitivemarketing #healthcare
Orphan Drugs Market to Surge to USD 486.51 Billion by 2032 as Rare Disease Innovation, Gene Therapies & Precision Medicine Reshape Global Healthcare - PR Newswire UK
Orphan Drugs Market to Surge to USD 486.51 Billion by 2032 as Rare Disease Innovation, Gene Therapies & Precision Medicine Reshape Global Healthcare  PR Newswire UK
dlvr.it
November 27, 2025 at 3:31 PM
Americans make great biologists because we are forged by the hardest challenge in all of biotech: getting flavor from a turkey
November 27, 2025 at 2:35 PM
Novo Nordisk backs biotech start-up targeting aging

https://www.newsbeep.com/ie/162576/

General Control enters Novo Nordisk’s Co-Creation Greenhouse to advance multiplex epigenetic editing for complex chronic disease. General Control,…
Novo Nordisk backs biotech start-up targeting aging - Ireland News Beep
General Control enters Novo Nordisk’s Co-Creation Greenhouse to advance multiplex epigenetic editing for complex chronic disease.
www.newsbeep.com
November 27, 2025 at 2:31 PM
Signal or noise? > Eye Gene Therapy Startups Scale Up As Pharma Interest Grows
- Citeline News & Insights >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #biotech #healthcare #pharma
Eye Gene Therapy Startups Scale Up As Pharma Interest Grows - Citeline News & Insights
Eye Gene Therapy Startups Scale Up As Pharma Interest Grows  Citeline News & Insights
dlvr.it
November 27, 2025 at 2:30 PM
Another Shanghai biotech is heading to HKEX.
Baopharma cleared its IPO hearing with a ~5B yuan valuation, planning to pour proceeds into core assets, subcutaneous antibiotic clinical trials in China/US, its synbio platform, and manufacturing scale-up.
November 27, 2025 at 2:14 PM
Granite Bio, a Basel-based startup rooted in Regensburg research, secures $100M to advance treatments for autoimmune diseases. A testament to the power of cross-border biotech collaboration!
transkript.de/artikel/2025/...
#GraniteBio
transkript.de
November 27, 2025 at 2:10 PM
👌 Fantastic tour of the Montreal Neurological Institute-Hospital site yesterday with the Biotech Connect team.
👉 Three stops at key locations on the site and an eye-opener experience.
More info and photos: www.linkedin.com/posts/carlba...
November 27, 2025 at 12:55 PM
👌 Fantastique visite du site du The Neuro (Montreal Neurological Institute-Hospital) hier avec équipe Biotech Connect.
👉 Trois arrêts à des points névralgiques du site et une expérience "eye opener".
+ d'infos et photos: www.linkedin.com/posts/carlba...
November 27, 2025 at 12:34 PM
Looking to launch or grow your career in biotech or biomanufacturing?

Build Your BioFuture: National Career & Info Fair for Biotechnology & Biomanufacturing Talent (co-hosted by SCN and CASTL) is happening January 27, 2026!

Learn more and register today. ➡️ stemcellnetwork.ca/training/wor...
November 27, 2025 at 12:33 PM
Vergleich der besten KI-Modelle für Biotech-Use-Cases 2025

Biotech-Use-Cases umfassen Bereiche wie Drug Discovery (z. B. Molekül-Design, Target-Identifikation), Protein Engineering (z. B. Strukturvorhersage), Genomik (z. B. Sequenzanalyse), personalisierte Medizin (z. B. Biomarker-Entdeckung) und…
Vergleich der besten KI-Modelle für Biotech-Use-Cases 2025
Biotech-Use-Cases umfassen Bereiche wie Drug Discovery (z. B. Molekül-Design, Target-Identifikation), Protein Engineering (z. B. Strukturvorhersage), Genomik (z. B. Sequenzanalyse), personalisierte Medizin (z. B. Biomarker-Entdeckung) und klinische Trials (z. B. Vorhersage von Outcomes). Basierend auf aktuellen Trends 2025 dominieren generative Modelle (z. B. Transformer-basierte) und spezialisierte Tools wie AlphaFold-Varianten. Der Markt wächst rasant (CAGR 19-20 % bis 2030), getrieben von Firmen wie Insilico Medicine, Recursion und Owkin.
labnews.io
November 27, 2025 at 12:20 PM
Signal or noise? > Europe Gene Therapy Market to Hit $8,780.77 Million by 2033
| - openPR.com >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharma #biotech #competitivemarketing #pharmaceutical
Europe Gene Therapy Market to Hit $8,780.77 Million by 2033 | - openPR.com
Europe Gene Therapy Market to Hit $8,780.77 Million by 2033 |  openPR.com
dlvr.it
November 27, 2025 at 12:01 PM
With emphasis recently in academia & biotech on generating massive-scale perturbation single-cell data (e.g. @recursionpharma.bsky.social, #TahoeTx, #XairaTx, and others), full transcript resolution will enable more detailed phenotyping for mechanistic biology...
November 27, 2025 at 11:59 AM